Stock Rich List
Nasdaq: PTGX

Protagonist Therapeutics insiders

The officers, directors and 10% owners of Protagonist Therapeutics, Inc. who hold the most stock, valued at the live PTGX price.

$124.02
PTGX today −$3.1M (−2.47%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
6
Their PTGX stock
$144M
Market value
$8.09B
Held by ranked insiders
1.78%

Insiders by value of PTGX holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Dinesh V. Patel, Ph.DPresident and CEO522,968$64.9M0.80%2116th
2Suneel GuptaChief Development Officer267,433$33.2M0.41%3474th
3David Y. LiuChief R&D Strategy Officer167,590$20.8M0.26%5042nd
4Arturo Molina, MDChief Medical Officer81,397$10.1M0.12%8699th
5Harold E. SelickDirector60,845$7.5M<0.1%10796th
6Asif AliChief Financial Officer59,003$7.3M<0.1%11055th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Protagonist Therapeutics; see each profile for the filing.